Cite

HARVARD Citation

    Chen, T. et al. (2018). A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer. Japanese journal of clinical oncology. pp. 242-247. [Online]. 
  
Back to record